Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia

Eur J Intern Med. 2023 Apr:110:104-106. doi: 10.1016/j.ejim.2022.11.033. Epub 2022 Dec 2.
No abstract available

Keywords: COVID-19; INFβ-1a; Repurposed drugs; SARS-CoV-2; Type-I interferons.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • Interferon beta-1a
  • Pneumonia* / drug therapy
  • SARS-CoV-2

Substances

  • Interferon beta-1a
  • Antiviral Agents